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Abstract Inducible T-cell kinase (ITK) is a member of the Tec
family of tyrosine kinases that are involved in signals emanating
from cytokine receptors, antigen receptors and other lymphoid
cell surface receptors. Stimulation of tyrosine phosphorylation
and activation of ITK by the T-cell antigen receptor, CD28 and
CD2 requires the presence of the Src family kinase Lck in
T-cells. We have previously demonstrated that the activation
of ITK by Src family kinases uses a phosphatidylinositol 3-ki-
nase pathway, which recruits ITK to the membrane via its
pleckstrin homology (PH) domain where it is acted upon by
Src. We have further explored the mechanism of this require-
ment for Src family kinases in the activation of ITK. We found
that deletion of the proline rich sequence found in the Tec ho-
mology domain of ITK results in reduced basal activity of ITK
approximately 50%. These di¡erences in the basal activity of
ITK were observed when the PH domain was deleted or when
the kinase was membrane targeted. Furthermore, this deletion
reduces the ability of the Src family kinase Lck to activate ITK,
as well as to induce the ITK mediated tyrosine phosphorylation
of its substrate PLCQ1. By contrast, deletion of the SH3 domain
of ITK resulted in a two-fold increase in the basal activity of
ITK, and allowed this mutant to have an enhanced response to
Lck. These results suggest that the proline rich region within the
Tec homology domain of ITK regulates its basal activity and its
response to Src family kinase signals. 3 2002 Federation of
European Biochemical Societies. Published by Elsevier Science
B.V. All rights reserved.
Key words: Inducible T-cell kinase; Src; Tyrosine kinase;
CD28; T-cell receptor
1. Introduction
The Tec family of non-receptor protein tyrosine kinases
includes inducible T-cell kinase (ITK) [1^3], Tec I and II
[4,5], Bmx [6], Txk/Rlk [7], and BTK [8]. Expression of ITK
is predominantly detected in T-cells and NK cells [1^3]. Mu-
tations in BTK are responsible for human X-linked agamma-
globulinemia and the murine X-linked immunode¢ciency,
where maturation of the B-cell compartment is impaired
[8,9]. ITK has an analogous function in T-cells as mice lacking
ITK have reduced numbers of mature thymocytes, with re-
duced proliferative responses following T-cell receptor (TcR)
crosslinking of their mature T-cells, and de¢cient TH2 cell
development [10,11]. ITK and BTK have been proposed to
act as ampli¢ers of signals from TcR and the B-cell receptor
[12,13].
ITK, like most of the other members of the Tec family of
kinases, has an Src homology 3 (SH3) and an Src homology 2
(SH2) domain. In addition, ITK has a pleckstrin homology
(PH) domain and a Tec homology (TH) domain that has a
GAP homology region and a proline rich region (PRR). This
PRR has been demonstrated to interact with the SH3 domains
of Src family kinase in vitro and in the yeast two-hybrid
system [14^16]; however, no interaction between ITK and
Src family kinases in vivo has been reported and the signi¢-
cance of these ¢ndings is unclear.
Tec kinases have been shown to be regulated by Src family
kinases by acting as direct substrates of these kinases [17^23].
We and others have determined that ITK, BTK, and BMX
are regulated by the actions of phosphatidylinositol 3-kinase
(PI 3-kinase) [18,24^26]. Cumulatively, these data suggest that
Src family kinases activate PI 3-kinase, which recruit Tec
family kinases to the membrane, where they are acted upon
by Src family kinases.
ITK is activated as a result of ligation of the T-cell antigen
receptor (TcR), CD28 and CD2, cell surface receptors found
on T-cells, and the FcOR found on mast cells [27^30]. In the
case of the TcR, CD28 and CD2, this activation event re-
quires the presence of the Src family kinase Lck [28,30,31].
Similarly, BTK is activated by the B-cell antigen receptor and
the FcOR and requires Src kinase activity [32,33]. In addition,
the GK subgroup of heterotrimeric G proteins can also acti-
vate BTK and other Tec family kinases, the mechanism of
which may involve the N-terminal region of the TH domain
[34]. As the PRR of the TH domain of Tec family kinases has
been reported to interact with Src family kinase in yeast and
in cells, as well as with the SH3 domain of ITK in an intra-
molecular fashion, we examined this region for a possible role
in the activation of ITK by Src family kinases. We report here
that the PRR of ITK is required for both normal basal activ-
ity and activation by Src family kinases. These data, along
with recently published ¢ndings on the activation of BTK
by GK, suggest that the TH domain is the target of regulation
of Tec family kinases by both tyrosine kinases (Src family
kinases) and G proteins.
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2. Materials and methods
2.1. Construction of expression plasmids
Wild-type (WT) ITK and mutants vPH and Kit/vPH have been
previously published [18]. The v-Src kinase inactive cDNA was a gift
of Dr. J. Michael Bishop (UCSF, San Francisco), and was cloned into
the mammalian expression vector pMEXneo. ITK mutants vPH PR,
Kit/vPH PR, v PR, and v SH3 ITK were generated by PCR or
recombination with previous mutants and cloned into the expression
vector pMEXHAneo or pG (A. August, unpublished). All ITK con-
structs were tagged at the N-terminus with the HA tag.
2.2. Cell culture and transfections
293 cells were grown in DMEM containing 10% fetal calf serum
and antibiotics at 37‡C with 5% CO2. Cells were transiently trans-
fected with calcium phosphate/DNA complexes as described [18].
2.3. Cell lysis, immunoprecipitation and kinase assays
Cell lysis, immunoprecipitation, SDS^PAGE, and Western blotting
were performed exactly as described [18]. Kinase assays were per-
formed exactly as described either with Sam68 as a substrate (Santa
Cruz Biotechnology, Santa Cruz, CA, USA) or without exogenous
substrate [18]. Tyrosine phosphorylation of substrates and the kinase
autophosphorylation was quanti¢ed by phosphor imager and cor-
rected for protein expression following probing the blots with anti-
HA antibodies. Western blots were quanti¢ed using the phosphor
imager in £uorescence mode and ECL+ (Amersham Pharmacia).
3. Results and discussion
3.1. The PR region of ITK regulates its basal activity
The PRR within the TH domain of Tec family kinases has
been demonstrated to interact with the SH3 domains of Src
family kinases in yeast [14]. In addition, this region was
shown to interact in an intramolecular fashion with ITK’s
own SH3 domain, suggesting a mechanism of regulation of
these kinases [16]. These investigators suggested that ITK was
regulated in an intramolecular fashion, with the SH3 domain
of ITK interacting with its PRR, leading to inhibition of ITK.
This model suggests that removal of either the PRR or the
SH3 domain of ITK should be su⁄cient to activate its kinase
activity. We therefore wanted to determine the behavior of a
mutant of ITK that lack the PRR or the SH3 domain, or both
(Fig. 1) and their regulation by the Src family kinase Lck. We
transfected 293 cells either with WT ITK, ITK lacking its
PRR (vPRR ITK), or ITK lacking its SH3 domain (vSH3
ITK), and determined their activity in vitro in autophosphor-
ylation (Fig. 2A) or in transphosphorylation of a substrate,
SAM68, a putative substrate of ITK (Fig. 2B, [16]). Note that
based on experimental data as well as homology with BTK,
ITK has two autophosphorylation sites, one in the catalytic
domain and the other in the SH3 domain, and removal of the
SH3 domain may have removed one of these putative auto-
phosphorylation sites [35]. It is therefore possible that if the
vSH3 mutant’s activity is una¡ected by the deletion of the
SH3 domain, it should have an apparent 50% reduced auto-
phosphorylation activity, but WT activity in the transphos-
phorylation assay. Examining autophosphorylation of the dif-
ferent mutants showed that removal of the PRR of ITK
results in an approximately 50% reduction in ability to auto-
phosphorylate (average of three experiments. Note that re-
moval of the PRR does not remove any tyrosine residues).
By contrast, removal of the SH3 domain results in an appar-
ent 1.5-fold increase in its ability to autophosphorylate (aver-
Fig. 1. Structure of the di¡erent ITK mutants used in this study.
vPRR ITK: PRR of TH domain deleted ITK; vPH ITK: PH do-
main deleted ITK; vPH PRR ITK: PH and PRR of TH domain
deleted ITK; vSH3 ITK: SH3 domain deleted ITK; Kit/vPH ITK:
murine c-Kit/vPH ITK fusion; Kit/vPH PR ITK: murine c-Kit/
vPH vPRR ITK fusion.
Fig. 2. The PR region of ITK regulates its basal autophosphoryla-
tion and transphosphorylation activity. A: 293 cells were transfected
with WT, vPRR or vSH3 mutants of ITK, lysed 2 days later and
ITK immunoprecipitated using anti-HA antibodies and analyzed for
kinase activity by in vitro kinase assay. Lane 1: WT ITK, lane 2:
vPRR ITK, lane 3: vSH3 ITK. Top panel: Labeling of ITK during
autophosphorylation. Bottom panel: The blot was probed with an
anti-HA antibody. Note that activity was determined after correct-
ing for expression of the respective mutants. B: 293 cells were trans-
fected with WT, vPRR or vSH3 mutants of ITK, lysed 2 days later
and ITK immunoprecipitated using anti-HA antibodies and ana-
lyzed for transphosphorylating activity in the presence of SAM68
by in vitro kinase assay. Lane 1: WT ITK, lane 2: vPRR ITK,
lane 3: vSH3 ITK. Top panel: Labeling of ITK and SAM68 during
kinase reaction. Bottom panel: The blot was probed with an anti-
HA antibody. Note that the blots were treated with KOH before
exposure and that the activity was determined after correcting for
expression of the respective mutants. Arrows indicate the position
of the ITK mutants.
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age of three experiments. Note that removal of the SH3 do-
main may have removed one of the two tyrosine residues that
can be autophosphorylated by ITK, and this may be an
underestimate by two-fold of its ability to autophosphorylate,
i.e. true autophosphorylation activity of this mutant may be
closer to three-fold). Examining transphosphorylation of an
exogenous substrate, SAM68, con¢rms these ¢ndings and as-
sumptions. The mutant lacking its PRR had an approximately
50% reduction in its ability to phosphorylate SAM68 (Fig.
2B). Surprisingly, the vSH3 mutant did not exhibit an in-
crease in its ability to phosphorylate SAM68, suggesting
that perhaps the SH3 domain of ITK was important for phos-
phorylating this substrate in vitro, a fact supported by the fact
that the SH3 domain of ITK interacts with SAM68 in vitro
[17]. These data suggest that in the basal state, the PRR pos-
itively regulates the activity of ITK both to autophosphory-
late, as well as in phosphorylating speci¢c substrates. By con-
trast, deletion of the SH3 domain of ITK increased its ability
to autophosphorylate without apparently increasing its ability
to phosphorylate an exogenous substrate in vitro, similar to
that seen with BTK [35], although this may also re£ect a
requirement for the SH3 domain in e⁄ciently phosphorylating
SAM68.
We then tested whether this di¡erence we saw would also be
seen in kinase mutants lacking the PH domain, as it is possi-
ble that the PH domain could be targeting these mutants to
the membrane and allowing for low level kinase activation,
with the PRR regulating this step. We have demonstrated that
the PH domain of ITK is su⁄cient to target a heterologous
protein (GFP) to the membrane in the absence of the TH
domain, and that there are no di¡erences in membrane target-
ing of PH vs. PHTH containing GFP fusion proteins ([36], A.
August, unpublished). In addition, the vPR mutant of ITK
had WT activity in phosphorylating the membrane bound
receptor CD28 (A. August, unpublished). However, to ad-
dress this, we therefore expressed WT ITK, PH domain de-
leted ITK (vPH ITK), or PH and PRR deleted ITK (vPH PR
ITK) in 293 cells and determined their ability to autophos-
phorylate and transphosphorylate SAM68 (Fig. 3A). Expres-
sion of the vPH mutant resulted in WT activity, while the
vPH PR mutant had more than 50% reduction in both its
autophosphorylation activity and its transphosphorylating ac-
tivity, suggesting that membrane localization was not a con-
trolling factor in the di¡erence in basal activity of the vPR
mutant of ITK (the white arrowheads indicate the position of
the phosphorylated SAM68, which runs just below the
vPHPRR ITK mutant on gels). To con¢rm this, we fused
the two mutants vPH and vPHPR to a membrane receptor
(c-Kit) so that both mutants had equal access to the mem-
brane, and measured their basal activity, as well as following
dimerization with the ligand for c-kit, SCF (Fig. 3B). In the
basal state, the vPHPR membrane localized ITK had approx-
imately 50% reduced activity compared to the vPH membrane
localized ITK, agreeing with our results with the WT and
vPH kinases. Interestingly, dimerization of the receptor chi-
meras did not result in increased activity, however, these re-
Fig. 3. Neither membrane targeting nor the PH domain a¡ects the
regulation of the basal activity by the PR region. A: 293 cells were
transfected with WT, vPH or vPH PRR mutants of ITK, lysed
2 days later and ITK immunoprecipitated using anti-HA antibodies
and analyzed by kinase activity by in vitro kinase assay using
SAM68 as an exogenous substrate. Lane 1: WT ITK, lane 2: vPH
ITK, lane 3: vPH PRR ITK. Top panel: Labeling of ITK during
autophosphorylation (the blot was treated with KOH before expo-
sure). Bottom panel: The blot was probed with an anti-HA anti-
body. White arrowheads indicate the phosphorylated SAM68.
B: 293 cells were transfected with Kit/vPH or Kit/vPHPRR mu-
tants of ITK. Two days later, cells were treated with SCF or vehicle
(RPMI) as indicated for 30 min, lysed, and ITK immunoprecipi-
tated using anti-HA antibodies and analyzed for kinase activity by
in vitro kinase assay and for the presence of phosphotyrosine by
anti-phosphotyrosine antibody. Lanes 1 and 2: Kit/vPH ITK, lanes
3 and 4: Kit/vPHPRR ITK. Top panel: The blot was probed with
an anti-phosphotyrosine antibody. Middle panel: Labeling of ITK
during autophosphorylation (the blot was treated with KOH before
exposure). Bottom panel: The blot was probed with an anti-HA
antibody. Arrows indicate the position of the ITK fusions.
Fig. 4. Kinase inactive Src reduces the basal activity of membrane
targeted vPH ITK to that seen in membrane targeted vPH PRR
ITK. 293 cells were transfected with Kit/vPH ITK in the presence
of absence of kinase inactive v-Src, or with Kit/vPHPRR mutant of
ITK. Two days later, cells were lysed, and ITK immunoprecipitated
using anti-HA antibodies and either analyzed for kinase activity by
in vitro kinase assay, and for the presence of phosphotyrosine by
anti-phosphotyrosine antibody. Lanes 1 and 5: mock transfections,
lanes 2 and 6: Kit/vPH ITK alone, lanes 3 and 7: Kit/vPH ITK
along with kinase inactive v-Src, lanes 4 and 8: Kit/vPHPRR ITK
alone. Lanes 1^4: Labeling of ITK during autophosphorylation (the
blot was treated with KOH before exposure), lanes 5^8: the blot
was probed with an anti-phosphotyrosine antibody. Bottom panel:
The blot was probed with an anti-HA antibody. Arrows indicate
the position of the ITK fusions. Expression of v-Src was con¢rmed
using anti-Src antibody 327 (data not shown).
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sults agree with our analysis of the other mutants that the
PRR regulates the basal activity of ITK.
These data support the model of SH3/PRR interaction in
ITK, but suggest that the PRR may play another role in the
regulation of ITK activity, and that mere deletion of this
region is not su⁄cient for deregulation of its activity. Thus
our data suggest that the SH3 domain does play a role in
down-regulating the activity of ITK, probably by interacting
with the PRR, but that the PRR is also important in regulat-
ing this activity independently of the SH3 domain.
3.2. Src kinases regulate the basal activity of ITK
Previous analysis of the TH domain of Tec kinases has
indicated that they bind to the SH3 domain of a number of
other proteins, including Src family kinases [14,37]. As Src
kinases also serve to activate ITK, we decided to ¢nd out if
Src kinases can also regulate the basal activity of ITK. We
therefore transfected 293 cells (which express endogenous
c-Src) with the membrane localized vPH mutant of ITK in the
absence or presence of kinase inactive v-Src, and compared its
ability to autophosphorylate with that of the membrane lo-
calized vPHPR mutant (Fig. 4) (we used v-Src kinase inactive
mutant because this is a more e¡ective Src dominant negative
than a c-Src kinase inactive due to the lack of C-terminal
tyrosine in v-Src, and therefore a constitutively open con¢g-
uration). Expression of kinase inactive Src along with the
membrane localized vPH ITK mutant (c-Kit/vPHPR ITK)
resulted in a reduction in autophosphorylation activity to
that seen in the membrane localized vPHPR ITK mutant,
suggesting that endogenous Src kinases may be interacting
with the PRR of ITK to regulate its basal activity, and that
removing that region prevents this regulation (Fig. 4). The
kinase inactive Src accomplishes the same purpose, interacting
with the PRR, without being able to phosphorylate ITK.
These data suggest either that Src kinases or some other mol-
ecule(s) regulated by Src kinases regulate ITK’s basal activity
by interacting with its PRR.
3.3. The PRR of ITK regulates the ability of Src kinase Lck
to activate ITK
The experiments described above show that the PRR of
ITK regulates its basal activity, probably by interacting with
Src kinases. As we and others have shown that ITK is acti-
vated by Src kinases, we decided to test if the PRR also
regulates the ability of Lck (a Src family kinases expressed
in T cells) to activate ITK. Fig. 5 shows the results of experi-
ments where we transfected WT ITK or the mutants analyzed
in Fig. 2 in the absence or presence of Lck, and analyzed the
activation of ITK. These experiments con¢rm our data in Fig.
2 that the basal activity of the vPR mutant of ITK is reduced
approximately two-fold compared to the WT (lanes without
Lck). In addition, they show that in the presence of Lck, the
WT ITK becomes activated, while the vPR mutant is not
activated, and the vSH3 domain mutant was ‘superactivat-
able’. These data suggest that removal of the PRR of ITK
a¡ected the ability of Lck to interact with it and therefore
activate its enzymatic activity, whereas removal of the SH3
domain resulted in an increased ability of Lck to interact with
ITK, allowing for ‘superactivation’ (note that all fold activa-
tion values are corrected for the expression level of the partic-
ular mutant as determined by densitometry, and compared to
the WT ITK).
3.4. The PR region a¡ects the ability of ITK to phosphorylate
substrates in cells
All of the experiments described above indicate that the
basal activity of ITK and ability to be activated by Lck are
controlled by its PRR. However, we wanted to determine if it
a¡ected the ability of ITK to phosphorylate exogenous sub-
strates in cells. We therefore took advantage of the fact that
one substrate for ITK is the enzyme PLCQ1 [38]. Transfection
of PLCQ1 along with either LCK alone or ITK alone resulted
in a low level of tyrosine phosphorylation of PLCQ1. How-
ever, cotransfecting PLCQ1 along with LCK and WT ITK, or
LCK with vSH3 ITK resulted in increased tyrosine phosphor-
ylation of PLCQ1 (Fig. 6A). By contrast, transfecting PLCQ1
with LCK and vPR ITK resulted in no increases in tyrosine
phosphorylation of PLCQ1 (Fig. 6B). We noted that the vSH3
mutant of ITK did not have increased ability to phosphory-
late PLCQ1, similar to our results in vitro with the SAM68
substrate. These data suggest that perhaps the SH3 domain of
ITK is important for its ability to phosphorylate substrates in
vitro and in vivo. Indeed, ITK has been reported to interact
with PLCQ1 via its SH3 domain in vivo [39].
These data suggest that the PRR within the TH domain of
ITK is important not only in the regulation of the basal ac-
tivity of ITK, but also for the activation of ITK by Src family
kinases, and thus its activation of downstream targets. Indeed,
Berg and colleagues recently reported that the PR of ITK was
important in its ability to inhibit the activation of NFAT in
transfected Jurkat cells [17]. The PRR of BTK has previously
been shown to interact with Src kinases in vitro and in the
yeast two-hybrid system [14,40]. However, while Yang et al.
have analyzed a BTK PRR mutant and showed that a kinase
inactive mutant carrying a PRR mutation was defective in
being transphosphorylated by an unknown kinase or kinases
stimulated by pervanadate, the tyrosine phosphorylation of
the WT BTK kinase carrying the mutant PRR was una¡ected
[40]. In addition, when Fluckiger et al. analyzed the role of the
Fig. 5. The PR region of ITK regulates the ability of ITK to be ac-
tivated by Lck. 293 cells were transfected with either the WT or the
indicated mutants of ITK in the presence or absence of Lck. Kinase
activity was determined as described. Lanes 1, 3 and 5: ITK or mu-
tant without Lck, lanes 2, 4 and 6: ITK or mutant with Lck. Top
panel: The blot was treated with KOH then exposed for autora-
diography. Activity was corrected for the expression level of the dif-
ferent mutants and expressed as fold increase or decrease compared
to WT ITK alone. Note that the vPRR mutant has reduced basal
activity and is not activated by Lck. Middle panel: The blot in the
top panel was probed with an anti-HA antibody. Bottom panel:
Lck kinase expression in the respective cells.
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PRR of BTK in phosphorylating being activated and phos-
phorylating PLCQ2, they found that this mutant was not de-
fective in being activated by Lyn or in phosphorylating PLCQ2
in vivo, suggesting that BTK may be less dependent than ITK
on the PRR for its activation and function as a kinase [41].
We also note that the TH domain is also the target of the GK
regulation of BTK, although the region involved is the
N-terminal region of the TH domain and vPR mutants retain
the ability to be activated by GK [42]. We propose that the
TH domain of ITK and other Tec family kinases may serve as
an important module for the regulation of both the basal
activity as well as the ability to be activated by upstream
e¡ectors.
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Fig. 6. The PR domain a¡ects Src induced ITK tyrosine phosphory-
lation of PLCQ1. A: 293 cells were transfected with PLCQ1 alone, or
with Lck, WT or vSH3 mutant of ITK in the presence or absence
of Lck. Cells were then lysed 2 days later, PLCQ1 immunoprecipi-
tated and tested for the presence of phosphotyrosine. Top panel:
Lane 1: PLCQ1 alone, lane 2: PLCQ1 plus WT ITK, lane 3: PLCQ1
plus Lck, lane 4: PLCQ1 plus Lck and WT ITK, lane 5: PLCQ1
plus vSH3 ITK, lane 6: PLCQ1 plus vSH3 ITK and Lck. Blot
probed with anti-phosphotyrosine. Middle panel: Blot in top panel
probed with anti-PLCQ1 antibodies. Bottom panel: Expression of
Lck and ITK mutants in the respective cells. B: 293 cells were
transfected with PLCQ1 alone, or with WT ITK in the presence or
absence of Lck, or vPRR mutant of ITK in the presence or absence
of Lck. Cells were then lysed 2 days later, PLCQ1 immunoprecipi-
tated and tested for the presence of phosphotyrosine. Top panel:
Lane 1: PLCQ1 alone, lane 2: PLCQ1 plus WT ITK, lane 3: PLCQ1
WT ITK and Lck, lane 4: PLCQ1 plus vPRR ITK, lane 5: PLCQ1
plus vPRR ITK and Lck. Blot probed with anti-phosphotyrosine
antibody. Middle panel: Blot in top panel probed with anti-PLCQ1
antibodies. Bottom panel: Expression of ITK mutants in the respec-
tive cells. Lck expression was con¢rmed by speci¢c Lck antibodies
(data not shown).
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